Antifungal activity of ketoconazole and other azoles against Malassezia furfur in vitro and in vivo

Infection

Volumn 25, Issue 5, 1997, Pages 303-306

  Strippoli, V ^a   Piacentini, A ^a   D'Auria, F D ^b   Simonetti, N ^b  

^a POLICLINICO UMBERTO I   (Italy)

^b Faculty of Pharmacy   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ECONAZOLE; FENTICONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; PYRROLE DERIVATIVE;

ADULT; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; HAIR; HUMAN; HUMAN TISSUE; MALASSEZIA FURFUR; MALE; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TINEA VERSICOLOR;

ADULT; ANTIFUNGAL AGENTS; HAIR; HUMANS; KETOCONAZOLE; MALASSEZIA; MALE; METABOLIC CLEARANCE RATE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 0030766983     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01720401     Document Type: Article

References (17)

1. Faergemann, J.: Pityrosporum ovale and skin diseases. Keio J. Med. 42 (1993) 91-104.
2. Faergemann, J., Djarv, L.: Tinea versicolor treatment and prophylaxis and ketoconazole. Cutis 30 (1982) 542-545.
3. Jones, H. E.: Ketoconazole today. A review of clinical experience. ADIS Press, Manchester 1987, pp. 45-48.
4. Faergemann, J.: In Vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare. Antimicrob. Agents Chemother. 26 (1984) 773-774.
5. Strippoli, V., Piacentini, A., D'Auria, F. D., Simonetti, N.: Sull'attività antifungina esercitata dal ketoconazolo verso Pityrosporum sp. Atti del 25° Congresso Nazionale di Microbiologia, Alghero 27-30 Settembre 1995.
6. Barnett, J. A., Payne, R. W., Yarrow, D.: YEAST: characteristics and identification (2nd ed.). Cambridge University Press 1990, p. 425.
7. Galgiani, J. N.: Susceptibility testing of fungi: current status of the standardization process. Antimicrob. Agents Chemother. 37 (1993) 2517-2521.
8. D'Auria, F. D., Simonetti, N., Strippoli, V.: Increased itraconazole antifungal activity by agar diffusion test. J. Microb. Meth. 20 (1994) 47-54.
9. Roberts, S. O. B.: Pityrosporum orbiculare: incidence and distribution of clinical normal skin. Br. J. Dermatol. 81 (1969) 264-269.
10. Rippon, J. W.: Medical mycology, W. B. Saunders Company, Philadelphia 1988, pp. 154-159.
11. Klotz, S. A., Hupper, M., Drutz, D. J.: Pulmonary vasculitis on intra-lipid therapy. N. Engl. J. Med. 306 (1982) 994-997.
12. Nenoff, P., Haustein, U. F.: Der Effekt anti-seborrhoischer Substanzen gegenüber Pityrosporum ovale "in vitro". Hautarzt 45 (1994) 464-467.
13. Richardson, M. D., Shankland, G.: Enhanced phagocytosis and intracellular killing of Pityrosporum ovale by human neutrophils after exposure to ketoconazole is correlated to changes of yeast cell surface. Mycoses 34 (1991) 29-33.
14. Schewach-Millet, M., Kahana, M., Levy, A., Yaron-Schiffer, O., Sommer, B., Shalish, L.: Ketoconazole an effective treatment for disseminated pityriasis versicolor. Isr. J. Med. Sci. 20 (1984) 417-419.
15. Epstein, E. H., Epstein, W. L.: New cell formation in the human sebaceous gland. J. Invest. Dermatol. 46 (1966) 453-458.
16. Wright, N. A.: The cell proliferation kinetics of the epidermis. In: Goldsmith, L. A. (ed.): Biochemistry and physiology of the skin. Oxford Press, New York 1983, pp. 203-229.
17. Harris, R., Jones, H. E., Artis, W. M.: Orally administered ketoconazole: route of delivery to the human stratum corneum. Antimicrob. Agents Chemother. 24 (1983) 876-882.